Rectal cancer is a malignant tumour arising in the rectum, the final part of the large bowel before the anus. These notes guide nursing students through risk factors, warning signs, diagnostic work-up, TNM staging, treatment pathways, stoma care, treatment-related complications and holistic nursing support.
Clinical reminder: persistent rectal bleeding, a new change in bowel habit, unexplained iron-deficiency anaemia, weight loss, progressive pelvic pain, or symptoms of bowel obstruction require timely clinical assessment. Do not assume bleeding is caused by haemorrhoids. Sudden severe abdominal pain, distension, vomiting, fever, collapse, or inability to pass stool and flatus requires emergency assessment.
After studying this topic, the learner should be able to:
- Define rectal cancer and distinguish it from anal cancer and colon cancer.
- Explain how rectal tumours may develop and identify important risk factors.
- Recognise common symptoms, alarm features and complications.
- Describe clinical assessment, biopsy, local and distant staging, and the role of multidisciplinary review.
- Outline treatment options for early, locally advanced and metastatic disease without treating one pathway as suitable for every patient.
- Plan nursing care through diagnosis, surgery, chemotherapy, radiotherapy, stoma formation, rehabilitation and palliative support.
Rectal cancer is a malignant growth arising in the rectum. The rectum is the final section of the large intestine, lying within the pelvis between the sigmoid colon and the anal canal. Its position close to the bladder, reproductive organs, pelvic nerves and anal sphincter affects both the spread of disease and the effects of treatment.
The most common rectal malignancy is adenocarcinoma, which develops from gland-forming cells in the bowel lining. Less common tumours may arise from other cell types and need specialist pathology. Rectal cancer and anal cancer are different diseases: their tissues of origin, staging and treatment are not the same. Rectal and colon cancers are both colorectal cancers, but rectal cancer treatment may include specific pelvic surgery and radiation planning because of the rectum’s anatomy.
Important: blood in stool, mucus, tenesmus or a change in bowel habit can have several causes. Symptoms alone do not diagnose cancer, and absence of symptoms does not exclude it. Diagnosis requires appropriate clinical assessment and tissue confirmation.
Many colorectal adenocarcinomas develop over time from abnormal changes in the bowel lining. Some begin in an adenomatous or serrated polyp, with additional cellular and genetic changes allowing invasion through the bowel wall. Other pathways, including mismatch-repair deficiency and inherited cancer syndromes, are important in a subset of patients. Not every polyp becomes cancer, and not every rectal cancer follows the same pathway.
As a tumour grows, it may ulcerate and bleed, narrow the rectal lumen, extend into surrounding tissues, or spread through lymphatic and blood vessels. Regional lymph nodes, liver and lungs are common sites considered during staging. Symptoms and the pattern of spread depend on tumour location, size, depth, biology and the patient’s overall health.
Risk factors increase the chance of disease but do not prove that an individual will develop cancer. Some patients have no identifiable risk factor.
| Risk factor | Why it matters | Nursing and health-promotion relevance |
|---|---|---|
| Increasing age | Risk generally rises with age, although colorectal cancer can occur in younger adults | Take symptoms seriously in every adult; do not dismiss persistent symptoms because a person is young |
| Personal history of colorectal polyps or cancer | Some lesions can recur or new lesions can develop | Reinforce surveillance and follow-up plans after polypectomy or cancer treatment |
| Family history and inherited syndromes | A first-degree relative with colorectal cancer or a syndrome such as Lynch syndrome or familial adenomatous polyposis may increase risk | Ask about family history and refer for risk assessment or genetic counselling where available |
| Inflammatory bowel disease | Long-standing ulcerative colitis or Crohn disease involving the colon can increase colorectal cancer risk | Encourage adherence to specialist surveillance and review of new bleeding or bowel changes |
| Lifestyle and metabolic factors | Physical inactivity, obesity, smoking, heavy alcohol use and some dietary patterns are associated with increased colorectal cancer risk | Offer practical, non-blaming advice on movement, tobacco cessation, alcohol moderation and balanced diet |
| Previous pelvic or abdominal radiation | May affect long-term risk in some individuals | Record treatment history and ensure new symptoms receive evaluation |
Colorectal screening aims to identify cancer early and, in some screening methods, detect and remove precancerous polyps. The appropriate test and starting age depend on the person’s age, symptoms, family history, prior polyps, inflammatory bowel disease and the screening guidance available in the country and health system. Some programmes use stool-based tests and others use endoscopy; local availability differs.
Screening is for people without alarm symptoms. A person with rectal bleeding, persistent bowel changes, unexplained anaemia, weight loss or a rectal mass needs diagnostic assessment rather than reassurance from a screening test alone. Nurses can support prevention by explaining risk, reducing stigma, encouraging attendance for indicated screening and promoting follow-up of abnormal results.
Early rectal cancer may cause few or no symptoms. When present, symptoms can be intermittent and may be mistaken for piles, infection or constipation.
| Clinical feature | Possible presentation | Assessment points |
|---|---|---|
| Rectal bleeding | Bright red blood on stool, in the toilet or mixed with stool; darker blood may also occur | Ask about amount, frequency, clots, dizziness, medications and associated symptoms; bleeding needs assessment even when haemorrhoids are present |
| Change in bowel habit | New constipation, diarrhoea, alternating pattern, increased frequency or change in stool calibre | Clarify onset, persistence, baseline pattern, diet and medication; note whether symptoms are progressive |
| Tenesmus or incomplete evacuation | Persistent urge to pass stool, rectal pressure or feeling that the bowel has not emptied | May occur with a low rectal tumour or other rectal disease; assess pain, stool passage and impact on daily activity |
| Mucus or altered stool | Mucus discharge, change in stool shape, or soiling | Document associated bleeding, urgency, pain and incontinence |
| Abdominal or pelvic discomfort | Cramping, pressure, bloating or pain that may become persistent | Assess distension, vomiting, bowel sounds when appropriate, passage of stool/flatus and red flags |
| Constitutional symptoms | Fatigue, weakness, reduced appetite, unexplained weight loss or pallor | Consider anaemia, nutritional compromise or advanced disease; review observations and investigations |
| Obstructive symptoms | Progressive constipation, colicky pain, abdominal distension, vomiting and inability to pass stool or flatus | Potential acute bowel obstruction: urgent assessment and surgical escalation are required |
Urgent escalation: heavy ongoing bleeding, fainting, signs of shock, severe abdominal pain, marked distension, repeated vomiting, fever, peritonism or inability to pass stool and flatus should not wait for a routine clinic appointment.
- Ask about the onset and progression of bleeding, bowel changes, tenesmus, mucus, pain, fatigue, appetite, weight change and ability to pass stool and flatus.
- Establish the patient’s normal bowel pattern and ask about constipation, diarrhoea, straining, incontinence and previous episodes.
- Ask about previous polyps, colorectal cancer, inflammatory bowel disease, abdominal or pelvic surgery, pelvic radiation and medicines such as anticoagulants or iron.
- Explore family history of colorectal or related cancers, age at diagnosis in relatives and known inherited syndromes.
- Assess nutrition, hydration, mobility, comorbidities, functional status, pain, psychosocial support, financial or transport barriers and the patient’s understanding of the problem.
- Use clear, respectful language. Rectal symptoms may feel embarrassing; privacy and a calm approach help the patient share important details.
- Assess general appearance, level of consciousness, pallor, hydration, nutritional status, pain and vital signs.
- Examine the abdomen for distension, tenderness, masses, guarding, bowel sounds where clinically indicated and signs of obstruction or peritonitis.
- A clinician may perform a digital rectal examination to assess a palpable lesion, its distance from the anal verge, mobility, tenderness and blood. Explain the procedure, obtain consent, preserve dignity and use a chaperone according to policy.
- Perianal inspection and proctoscopy or sigmoidoscopy may be used to assess a low lesion. Findings must be interpreted with endoscopy, histology and imaging.
- Do not delay urgent referral or resuscitation to complete a routine examination in an unstable patient.
Rationale: a focused history and examination identify alarm features, assess the urgency of care, establish baseline function and guide diagnostic testing. A normal digital rectal examination does not exclude a lesion higher in the rectum or elsewhere in the colon.
Diagnosis and staging are separate steps. Biopsy confirms the tumour type. Imaging and other tests then estimate how far disease has spread and help plan treatment.
| Investigation | Purpose | Nursing considerations |
|---|---|---|
| Full colonoscopy with biopsy | Visualises the rectum and colon, identifies the lesion, obtains tissue and checks for synchronous polyps or tumours | Explain preparation and consent; follow fasting and bowel-cleansing instructions; monitor hydration and report significant bleeding, severe pain or fever afterward |
| Proctoscopy or flexible sigmoidoscopy | Assesses a rectal lesion or distal bowel, and can support biopsy or localisation | Explain positioning and expected sensations; support privacy and follow the clinician’s preparation orders |
| Pelvic MRI | Key local staging test for depth of invasion, mesorectal fascia, circumferential resection margin, sphincter involvement and regional nodes | Screen for MRI safety concerns, explain stillness and duration, and communicate anxiety, pain or implanted devices to the imaging team |
| CT chest, abdomen and pelvis | Looks for distant spread, including lung or liver metastases, and assesses other abdominal disease | Check ordered contrast precautions, renal history and allergy information; explain that CT contributes to staging but does not replace biopsy |
| Endorectal ultrasound | May help assess depth and local nodes in selected early tumours | Provide preparation and reassurance according to the local procedure protocol |
| Complete blood count and chemistry tests | Assess anaemia, infection, renal/liver function, hydration and fitness for planned treatment | Collect samples correctly, monitor symptoms of anaemia and report critical results promptly |
| Carcinoembryonic antigen (CEA) | Baseline marker that can assist prognosis and follow-up in some patients; it is not a stand-alone screening or diagnostic test | Explain the purpose and avoid presenting a normal result as proof that cancer is absent |
| Tumour mismatch-repair / microsatellite-instability testing | May identify inherited risk and guide treatment decisions, including immunotherapy in selected disease | Explain the reason for tissue testing and facilitate genetics or oncology referral when advised |
| Histopathology | Confirms malignancy and tumour type; resection specimens provide margins, nodes and other pathological features | Ensure specimens are labelled and transported according to policy; communicate that treatment depends on the final report |
The TNM system describes the primary tumour (T), regional lymph nodes (N) and distant metastasis (M). Clinical stage is estimated before treatment; pathological stage is based on tissue removed at surgery. Exact staging is made by the specialist team from MRI, CT, endoscopy and pathology.
| Stage group (simplified) | General meaning | Clinical relevance |
|---|---|---|
| Stage 0 | Abnormal malignant cells are limited to the innermost lining (in situ) | Selected lesions may be treated with local removal; pathology and margins determine adequacy |
| Stage I | Tumour has invaded the bowel wall but has not spread to regional nodes or distant organs | Local excision or rectal resection may be considered for carefully selected patients |
| Stage II | Tumour extends through the bowel wall or into nearby structures without regional node involvement | Preoperative treatment and surgery may be advised depending on MRI risk features and tumour location |
| Stage III | Regional lymph nodes are involved, without distant metastasis | Often requires multimodal treatment planned by a multidisciplinary team |
| Stage IV | Disease has spread to distant organs or sites | Treatment may combine systemic therapy, selected surgery or local treatment of metastases, symptom relief and palliative care |
Staging is not the same as grading. Stage describes extent of spread. Grade describes how abnormal the cancer cells look and how they behave under the microscope. The team also considers tumour height, margins, sphincter involvement, molecular markers, response to treatment, comorbidities and the patient’s preferences.
Rectal cancer care is planned by a multidisciplinary team that may include colorectal surgeons, medical and radiation oncologists, radiologists, pathologists, specialist nurses, stoma therapists, nutrition professionals, physiotherapists, psychologists and palliative-care clinicians. The plan depends on stage, MRI findings, tumour location, pathology, molecular features, fitness, fertility and function priorities, local resources and the patient’s goals.
| Disease situation | Possible treatment approaches | Key nursing focus |
|---|---|---|
| Very early / selected stage 0 or T1 disease | Endoscopic polypectomy or transanal local excision for appropriately selected lesions; additional radical surgery or other treatment may be needed if pathology shows high-risk features | Support bowel preparation, post-procedure observation, explanation of histology and follow-up plan |
| Resectable localised rectal cancer | Rectal resection with mesorectal excision; low anterior resection may preserve the anal sphincter in suitable patients | Prepare for major pelvic surgery, monitor postoperative recovery and teach bowel-function expectations |
| Locally advanced or node-positive disease | Preoperative chemotherapy and/or chemoradiotherapy, total neoadjuvant therapy in selected pathways, followed by surgery; some carefully selected complete responders may enter an organ-preservation surveillance pathway in an experienced programme | Coordinate appointments; monitor treatment toxicities, nutrition, hydration, blood counts, pain, skin and bowel function; reinforce follow-up |
| Low tumour involving sphincter or pelvic structures | Abdominoperineal resection or other extended surgery may be considered when sphincter preservation is not oncologically or functionally appropriate; this commonly results in a permanent end colostomy | Offer early stoma education, body-image support and realistic discussion of continence and sexual/urinary effects |
| Metastatic or recurrent disease | Systemic chemotherapy, targeted therapy or immunotherapy for selected tumour biology; selected liver/lung metastasis surgery or ablation; radiotherapy or surgery for local symptoms; supportive and palliative care | Monitor treatment adverse effects, symptom burden and goals of care; coordinate referrals and family support with the patient’s consent |
| Acute obstruction, perforation or uncontrolled bleeding | Urgent stabilisation and surgical/oncology review; diversion, resection or other intervention is determined by the specialist team and clinical condition | Recognise deterioration, keep nil by mouth if directed, establish ordered access and monitoring, and prepare for transfer or theatre |
- Local excision: removes a small, carefully selected early lesion through the anus without removing the whole rectum. It is not suitable for every tumour; deeper invasion, poor differentiation, lymphovascular invasion, positive margins or other high-risk pathology may require further treatment.
- Low anterior resection with total mesorectal excision: removes the rectal tumour and surrounding mesorectal tissue, reconnecting the bowel when feasible. A temporary diverting ileostomy may protect a low anastomosis while it heals.
- Abdominoperineal resection: removes the rectum, anal canal and sphincter when necessary for tumour clearance or when a safe functional sphincter-preserving operation is not appropriate. It results in a permanent end colostomy.
- Diverting stoma: temporarily or permanently diverts stool to support healing, relieve obstruction or protect a surgical join. The type and duration are individual decisions.
Radiation and chemotherapy can be given before, after or instead of surgery in selected pathways. The timing is not universal. Treatment decisions should be made by the cancer team using current protocols and shared decision-making; nursing staff should explain the agreed plan and direct treatment-choice questions to the responsible clinicians.
Systemic treatment and pelvic radiotherapy can shrink or control cancer but can also cause adverse effects. The exact risks depend on the medicines, dose, treatment field and individual response. Use the oncology service protocol for monitoring and patient instructions.
| Potential problem | Assessment and nursing intervention | Rationale |
|---|---|---|
| Neutropenia and infection risk | Review blood counts as ordered; teach urgent reporting of fever, chills, sore throat, cough, dysuria or wound changes; follow infection-prevention measures | Early assessment and treatment of infection are important when immune defences are reduced |
| Anaemia, fatigue and weakness | Assess pallor, breathlessness, dizziness, activity tolerance and haemoglobin; plan rest periods and safe mobilisation; escalate worsening symptoms | Supports safety and may identify treatment-related or tumour-related blood loss |
| Nausea, vomiting, diarrhoea or poor intake | Record intake/output, weight and stool pattern; administer prescribed antiemetics and bowel medicines; encourage small tolerated meals and ordered fluids; report dehydration or severe diarrhoea | Reduces fluid and nutritional compromise and supports treatment completion |
| Mucositis or oral discomfort | Inspect oral mucosa, encourage gentle oral care and report pain, ulceration, bleeding or difficulty swallowing | Oral toxicity can interfere with eating, drinking and infection prevention |
| Peripheral neuropathy | Ask about numbness, tingling, pain, balance or difficulty with buttons and walking; protect from burns and falls and report progression | Some chemotherapy can affect peripheral nerves and increase injury risk |
| Hand-foot skin reaction | Inspect palms and soles; teach the patient to report redness, painful swelling, cracking or blistering and follow the oncology team’s skin-care plan | Early management may reduce pain and interruption of daily activities |
| Radiation-related bowel and skin effects | Assess diarrhoea, urgency, tenesmus, urinary irritation, fatigue and skin reaction in the treatment field; reinforce prescribed skin care and fluids | Pelvic radiation can irritate nearby bowel, bladder and skin; symptoms may need treatment adjustment |
| Emotional distress and uncertainty | Invite questions, explain what is known and what remains pending, assess anxiety and coping, and offer support services | Clear communication and early supportive referral improve shared understanding and coping |
| Nursing action | Rationale |
|---|---|
| Verify identity, procedure, consent status, allergies, prescribed bowel preparation, fasting plan, medication instructions and required investigations. | Prevents avoidable delays and supports safe anaesthesia and surgery. |
| Record baseline vital signs, pain, bowel pattern, continence, nutrition, weight, mobility, skin condition, urinary and sexual concerns when relevant. | Provides a comparison for postoperative assessment and identifies needs for rehabilitation or referral. |
| Review blood count, renal and liver function, group and cross-match or other tests as ordered; report abnormal results. | Identifies anaemia, organ dysfunction or other issues that may affect treatment readiness. |
| Support preoperative nutritional assessment and prescribed optimisation; refer poor intake, significant weight loss or dehydration to the team. | Malnutrition and dehydration can complicate recovery and wound healing. |
| Provide clear teaching on the planned operation, expected pain control, early mobilisation, breathing exercises, diet, bowel recovery, possible stoma and tubes. | Reduces uncertainty and prepares the patient for active participation in recovery. |
| If a stoma may be created, arrange preoperative stoma-nurse review and site marking by a qualified clinician where available. | Early preparation and suitable site selection support appliance use and self-care. |
| Assess anxiety, body-image concerns, fertility and sexual-function questions; refer to the relevant clinician or counsellor with consent. | Rectal cancer treatment can affect pelvic function and relationships; early discussion allows informed support. |
| Use privacy, culturally respectful language and an interpreter when needed; involve family only with the patient’s agreement. | Protects dignity and improves understanding and shared decision-making. |
Postoperative care depends on the operation, anastomosis, stoma, comorbidities and institutional recovery pathway. Monitor the patient closely and follow prescribed orders.
| Nursing action | Rationale |
|---|---|
| Monitor airway, breathing, circulation, consciousness, temperature, pain, fluid balance and urine output after anaesthesia. | Supports early recognition of haemorrhage, sepsis, dehydration, respiratory complications or deterioration. |
| Assess abdominal pain, distension, nausea, vomiting, bowel sounds when indicated, passage of flatus/stool and signs of peritonism; escalate unexpected changes. | May identify ileus, obstruction, intra-abdominal infection or anastomotic leak. |
| Inspect abdominal, perineal and stoma sites; report bleeding, worsening redness, swelling, separation, purulent discharge, foul odour or necrotic tissue. | Early detection allows assessment and treatment of wound or stoma complications. |
| Administer prescribed analgesia and antiemetics; reassess pain, sedation, respiratory status and ability to move. | Comfort supports coughing, breathing and mobilisation while preventing unrecognised adverse drug effects. |
| Encourage progressive mobilisation, breathing exercises and prescribed venous-thromboembolism prevention. | Reduces risks from prolonged immobility after major pelvic surgery. |
| Advance fluids and diet according to the surgical plan; assess tolerance, nausea, hydration and nutritional needs. | Supports recovery while identifying intolerance or complications early. |
| Monitor urinary output, bladder discomfort and ability to void after catheter removal; report retention or reduced output. | Pelvic dissection, anaesthesia and analgesia can affect bladder emptying. |
| Observe stoma colour, moisture, swelling, output and surrounding skin; report dusky/black tissue, no output with pain or distension, high output or appliance leakage. | Changes may signal impaired perfusion, obstruction, dehydration or skin injury. |
| Teach stoma care in manageable steps and allow supervised practice with an ostomy nurse when available. | Repeated practical teaching builds confidence and supports safe self-care at home. |
| Assess bowel function, continence, frequency, urgency and fear of defecation after sphincter-preserving surgery. | Low anterior resection can change bowel frequency and urgency; symptoms need support and follow-up. |
| Document observations, intake/output, wound and stoma status, bowel/urinary function, teaching and escalation. | Accurate documentation supports continuity and timely decisions. |
A colostomy or ileostomy may be temporary or permanent. The patient may initially feel grief, anxiety, anger, shame or fear of odour and leakage. Treat these reactions respectfully and avoid assuming that adaptation occurs quickly.
- Explain the purpose and type of stoma and what output may look like; clarify which changes require urgent contact.
- Demonstrate emptying and changing the pouch, measuring the stoma if required, protecting peristomal skin and disposing of supplies hygienically.
- Teach the patient to seek help for a dark or black stoma, severe pain, increasing swelling, absent output with cramps or vomiting, very high output, dehydration, skin breakdown or repeated appliance failure.
- Review fluids and food according to the stoma type and individual plan. Do not make blanket restrictions; refer persistent diarrhoea, blockage concerns or major dietary questions to the stoma team.
- Discuss clothing, bathing, travel, work, exercise, intimacy and supply access in a practical, private way.
- Use teach-back and encourage a chosen caregiver to learn care only if the patient wants this support.
| Possible nursing diagnosis | Expected outcome | Priority interventions |
|---|---|---|
| Acute pain related to tumour, obstruction or surgical incision | Patient reports pain at an acceptable level and can rest, breathe deeply and mobilise | Assess location, severity and associated features; administer prescribed analgesia; reassess response; escalate sudden severe pain or pain with distension/fever. |
| Imbalanced nutrition: less than body requirements | Patient maintains or improves intake, hydration and weight according to the care plan | Monitor intake, weight, nausea, stool losses and swallowing/oral problems; offer ordered nutritional support and refer persistent weight loss or poor intake. |
| Diarrhoea or altered bowel elimination related to tumour or treatment | Patient maintains hydration and reports manageable bowel symptoms | Record stool frequency and features; monitor fluid balance and skin; administer prescribed medicines; report blood, fever, severe pain or dehydration. |
| Risk for infection related to malignancy, chemotherapy, surgery or stoma | Patient remains free of untreated infection and knows when to seek help | Monitor temperature and clinical status; follow infection-prevention measures; review blood counts as ordered; teach urgent fever reporting during systemic therapy. |
| Disturbed body image or anxiety related to diagnosis, pelvic surgery or stoma | Patient expresses concerns and identifies support and coping strategies | Provide privacy and honest information; invite questions; involve stoma nurse, counsellor or support services with consent; respect readiness to learn. |
| Deficient knowledge related to treatment, stoma care or follow-up | Patient or chosen caregiver can explain medicines, warning signs, wound/stoma care and follow-up | Teach in short sessions; use demonstration and teach-back; provide accessible written instructions and contact information. |
| Risk for impaired skin integrity related to diarrhoea, mucus, immobility or appliance leakage | Perianal, operative and peristomal skin remain intact or show improvement | Inspect skin, cleanse gently, apply prescribed protection, correct appliance fit with specialist support and report breakdown or infection. |
| Complication | Features | Nursing response |
|---|---|---|
| Large-bowel obstruction | Progressive constipation, colicky pain, distension, vomiting and inability to pass stool or flatus | Urgent escalation; monitor vital signs and hydration; follow nil-by-mouth, IV and preparation orders |
| Perforation and peritonitis | Sudden severe pain, guarding, fever, tachycardia, hypotension or collapse | Emergency response, rapid surgical review and resuscitation according to protocol |
| Chronic blood loss and anaemia | Rectal bleeding, pallor, fatigue, dizziness, breathlessness or reduced exercise tolerance | Assess bleeding and observations; review ordered tests; report symptomatic or worsening anaemia |
| Local invasion or fistula | Pelvic pain, urinary symptoms, recurrent infection or abnormal communication between organs | Document symptoms, protect skin and dignity, and refer promptly for specialist assessment |
| Metastatic disease | Symptoms depend on involved organs; may include weight loss, abdominal discomfort, jaundice, cough or bone pain | Assess symptom burden and function; coordinate oncology and palliative support |
| Anastomotic leak or pelvic sepsis after surgery | Fever, tachycardia, worsening abdominal/pelvic pain, ileus, purulent drainage or systemic deterioration | Escalate urgently and prepare for investigations and treatment as directed |
| Low anterior resection bowel dysfunction | Frequency, urgency, clustering, leakage or difficulty evacuating after low rectal surgery | Provide education, skin care, symptom diary and referral for specialist bowel rehabilitation |
| Treatment-related toxicity | Neutropenia, mucositis, diarrhoea, neuropathy, fatigue, skin injury, nausea or urinary irritation | Assess early, follow oncology protocols, support hydration/nutrition and report severe or progressive effects |
A cancer diagnosis can affect identity, family roles, finances, relationships, body image, fertility, sexuality and spiritual wellbeing. Pelvic surgery and radiation may affect urinary, bowel and sexual function. Some patients need a temporary or permanent stoma. Ask permission before discussing sensitive concerns, use inclusive language and avoid promises about cure or function.
- Assess distress, social support, transport, costs and the patient’s preferred decision-making partners.
- Explain the purpose of each test and treatment in language the patient understands; check understanding and invite questions.
- Refer pain, nutrition, stoma, fertility, sexual health, mental health and financial-support concerns to the appropriate team or service.
- Support symptom relief and quality of life alongside disease-directed treatment. Palliative care can be introduced for symptom support at any stage when helpful.
- Respect cultural beliefs and informed choices while promptly addressing emergencies and maintaining confidentiality.
- Provide a written list of medicines, how to take them, common side effects, clinic appointments and whom to contact for urgent concerns.
- Teach wound, perineal and stoma care as applicable; arrange supplies and specialist follow-up before discharge when possible.
- Advise urgent review for fever during chemotherapy, heavy bleeding, worsening abdominal pain or distension, repeated vomiting, inability to pass stool/flatus, reduced urine, collapse, wound discharge or a dark stoma.
- Encourage gradual return to activity, adequate nutrition and hydration according to the treatment plan, and avoidance of lifting or activity that conflicts with surgical instructions.
- Explain that follow-up may include clinical review, CEA testing, imaging, colonoscopy and assessment of bowel, urinary, sexual and stoma function. The schedule is individual and should follow the oncology team’s plan.
- Reinforce that new bleeding or bowel symptoms after treatment should still be reported rather than assumed to be a normal long-term effect.
- Define rectal cancer and state why it is distinguished from anal cancer.
- List five risk factors and four alarm symptoms of rectal cancer.
- Why does a normal CEA result not rule out rectal cancer?
- Differentiate clinical staging from pathological staging.
- What information does pelvic MRI provide during local staging?
- Compare local excision, low anterior resection and abdominoperineal resection.
- List six priority nursing observations after rectal cancer surgery.
- What assessment and teaching are important for a patient with a new ileostomy or colostomy?
- State warning signs that require urgent review during chemotherapy or after discharge.
- Give examples of psychosocial and functional needs that should be addressed by the multidisciplinary team.
- Rectal cancer commonly presents with bleeding or a persistent bowel-habit change, but early disease may be silent.
- Do not attribute persistent rectal bleeding to haemorrhoids without appropriate assessment.
- Colonoscopy and biopsy confirm the diagnosis; pelvic MRI and CT help stage disease and guide the treatment plan.
- Treatment is multidisciplinary and may combine surgery, chemotherapy, radiotherapy, targeted therapy, immunotherapy or surveillance depending on stage and tumour features.
- Stoma formation may be temporary or permanent. Practical teaching, dignity, supplies and follow-up are central to safe discharge.
- Nurses monitor complications, treatment toxicity, bowel and urinary function, nutrition, psychosocial distress and the patient’s goals throughout care.
- National Cancer Institute. Rectal Cancer Treatment (PDQ®)–Health Professional Version. Evidence-based information on staging and treatment options. NCI PDQ.
- American Society of Colon and Rectal Surgeons (ASCRS). Rectal Cancer. Patient information on symptoms, diagnostic tests, staging, treatment and follow-up. ASCRS Rectal Cancer information.
- American Society of Colon and Rectal Surgeons. Clinical Practice Guidelines for the Management of Rectal Cancer. 2020, with 2023 supplement. ASCRS guideline and 2023 supplement.
- National Cancer Institute. Colorectal Cancer Prevention (PDQ®)–Health Professional Version. Screening and prevention information. NCI prevention summary.